Making the right choice: Optimizing rt-PA and eptifibatide lysis, an in vitro study

Thrombosis Research

Volumn 126, Issue 4, 2010, Pages

  Shaw, George J ^a,b   Meunier, Jason M ^a   Lindsell, Christopher J ^a   Pancioli, Arthur M ^a   Holland, Christy K ^b,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b 705 Engineering Research Center   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; EPTIFIBATIDE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BLOOD CLOT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; MALE; MICROSCOPY; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL;

BLOOD COAGULATION; HUMANS; PEPTIDES; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECOMBINANT PROTEINS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 77957153485     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.07.020     Document Type: Article

References (47)

1. H.P. Adams Jr., T.G. Brott, A.J. Furlan, C.R. Gomez, J. Grotta, and C.M. Helgason Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association Circulation 94 1996 1167 1174
2. NINDS Tissue plasminogen activator for acute ischemic stroke NEJM 333 1995 1581 1587
3. A.V. Alexandrov, C.A. Molina, J.C. Grotta, Z. Garami, S.R. Ford, and J. Alvarez-Sabin Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke N Engl J Med 351 2004 2170 2178
4. C. Brekenfeld, L. Remonda, K. Nedeltchev, F.V. Bredow, C. Ozdoba, and R. Wiest Endovascular neuroradiological treatment of acute ischemic stroke: Techniques and results in 350 patients Neurol Res 27 2005 S29 S35
5. A.M. Pancioli, and T.G. Brott Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in acute ischaemic stroke: scientific rationale and available evidence CNS Drugs 18 2004 981 988
6. H.P. Adams Jr., T.G. Brott, A.J. Furlan, C.R. Gomez, J. Grotta, and C.M. Helgason Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association Stroke 27 1996 1711 1718
7. C.P. Cannon Evolving management of ST-segment elevation myocardial infarction: update on recent data Am J Cardiol 98 2006 10Q 21Q
8. H.P. Adams Jr., M.B. Effron, J. Torner, A. Davalos, J. Frayne, and P. Teal Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of an International Phase III Trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II) Stroke 39 2008 87 99 10.1161/strokeaha.106.476648
9. Investigators AbESTT Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial Stroke 36 2005 880 890
10. A.I.M.D. Qureshi, P.R.N. Harris-Lane, J.F.M.D. Kirmani, N.M.D. Janjua, A.A.P.D. Divani, and Y.M.M.D. Mohammad Intra-arterial Reteplase and Intravenous Abciximab in Patients with Acute Ischemic Stroke: An Open-label, Dose-ranging, Phase I Study Neurosurgery 59 2006 789 797
11. A.M. Pancioli, J. Broderick, T. Brott, T. Tomsick, J. Khoury, and J. Bean The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial Stroke 39 2008 3268 3276
12. U. Cincinnati Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-ER NCT00894803) 2009
13. G.J. Shaw, M. Sperling, and J.M. Meunier Long-term stability of recombinant tissue plasminogen activator at - 80 C BMC Res Notes 2 2009 117
14. G.J. Jaffe, G.D. Green, and G.W. Abrams Stability of recombinant tissue plasminogen activator Am J Ophthalmol 108 1989 90 91
15. G.J. Shaw, J.M. Meunier, S.L. Huang, C.J. Lindsell, D.D. McPherson, and C.K. Holland Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes Thromb Res 124 2009 306 310
16. J.M. Meunier, C.K. Holland, A.M. Pancioli, C.J. Lindsell, and G.J. Shaw Effect of low frequency ultrasound on combined rt-PA and eptifibatide thrombolysis in human clots Thromb Res 123 2009 528 536
17. M. Nedelmann, C. Brandt, F. Schneider, B.M. Eicke, O. Kempski, and F. Krummenauer Ultrasound-induced blood clot dissolution without a thrombolytic drug is more effective with lower frequencies Cerebrovasc Dis 20 2005 18 22
18. B.M. Hardig, J. Carlson, and A. Roijer Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone BMC Cardiovasc Disord 8 2008 19
19. P. Winter, H. Shukla, S. Caruthers, M. Scott, R. Fuhrhop, and J. Robertson Molecular imaging of human thrombus with computed tomography Acad Radiol 12 Suppl 1 2005 S9 S13
20. X. Yu, S.K. Song, J. Chen, M.J. Scott, R.J. Fuhrhop, and C.S. Hall High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent Magn Reson Med 44 2000 867 872
21. C. Francis, and S. Totterman Magnetic resonance imaging of deep vein thrombi correlates with response to thrombolytic therapy Thromb Haemost 73 1995 385 391
22. M. Loren, L.J. Garcia Frade, M.C. Torrado, and J.L. Navarro Thrombus age and tissue plasminogen activator mediated thrombolysis in rats Thromb Res 56 1989 67 75
23. G.J. Shaw, N. Bavani, A. Dhamija, and C.J. Lindsell Effect of mild hypothermia on the thrombolytic efficacy of 120 kHz ultrasound enhanced thrombolysis in an in-vitro human clot model Thromb Res 117 2006 603 608
24. S.V. Marinkovic, M.M. Miliasavljevic, M.S. Kovacevic, and Z.D. Stevia Perforating branches of the middle cerebral artery: Microanatomy and clinical significance of their intracerebral segments Stroke 15 1958 1022 1029
25. X. Tao, X.J. Yu, B. Bhattarai, T.H. Li, H. Jin, and G.W. Wei Microsurgical anatomy of the anterior communicating artery complex in adult Chinese heads Surg Neurol 65 2006 151 161
26. J.Y. Cheng, G.J. Shaw, and C.K. Holland In vitro microscopic imaging of enhanced thrombolysis with 120-kHz ultrasound in a human clot model Acoust Res Lett Online 6 2005 25 29
27. J.M. Meunier, C.K. Holland, C.J. Lindsell, and G.J. Shaw Duty Cycle Dependence of Ultrasound Enhanced Thrombolysis in a Human Clot Model Ultrasound Med Biol 33 2007 576 583
28. E. Seifried, P. Tanswell, D. Ellbruck, W. Haerer, and A. Schmidt Pharmacokinetics and haemostatic status during consecutive infusions of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction Thromb Haemost 61 1989 497 501
29. B.E. Tardiff, L.K. Jennings, R.A. Harrington, D. Gretler, R.F. Potthoff, and D.A. Vorchheimer Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUIT Circulation 104 2001 399 405
30. I.C. Gilchrist, J.C. O'Shea, T. Kosoglou, L.K. Jennings, T.J. Lorenz, and M.M. Kitt Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention Circulation 104 2001 406 411
31. J.E. Tcheng, J.D. Talley, J.C. O'Shea, I.C. Gilchrist, N.S. Kleiman, and C.L. Grines Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study) Am J Cardiol 88 2001 1097 1102
32. T. Yasuda, H.K. Gold, J.T. Fallon, R.C. Leinbach, J.L. Guerrero, and L.E. Scudder Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs J Clin Investig 81 1988 1284 1291
33. G.J. Shaw, J.M. Meunier, C.J. Lindsell, and C.K. Holland Tissue plasminogen activator concentration dependence of 120 kHz ultrasound-enhanced thrombolysis Ultrasound Med Biol 34 2008 1783 1792
34. J.M. Meunier, C.K. Holland, C.J. Lindsell, and G.J. Shaw Duty cycle dependence of 120 kHz ultrasound enhanced thrombolysis in human clot Ultrasound Med Biol 33 2007 576 783
35. J.M. Meunier, D.A.B. Smith, C.K. Holland, S. Huang, D.D. McPherson, and G.J. Shaw 120 kHz pulsed ultrasound enhanced thrombolysis with tissue plasminogen activator-loaded echogenic liposomes J Acoust Soc Am 122 2007 3052
36. P. Tanswell, E. Seifried, P.C. Su, W. Feuerer, and D.C. Rijken Pharmacokinetics and systemic effects of tissue-type plasminogen activator in normal subjects Clin Pharmacol Ther 46 1989 155 162
37. S.S. Jambhekar, and P.J. Breen Basic Pharmacokinetics 2009 Pharmaceutical Press London, UK
38. R.D. Schoenwald Pharmacokinetic Principles of Dosing Adjustments: Understanding the Basics 2001 Technomic Publishing Company, Inc. Lancaster, PA
39. A. Cohen Pharmacokinetics of the Recombinant Thrombolytic Agents: What is the Clinical Significance of Their Different Pharmacokinetic Parameters? BioDrugs 11 1999 115 123
40. D.D. Gretler Pharmacokinetic and pharmacodynamic properties of eptifabatide in healthy subjects receiving unfractionated heparin or the low-molecular-weight heparin enoxaparin Clin Ther 25 2003 2564 2574
41. D.D. Gretler, R. Guerciolini, and P.J. Williams Pharmacokinetic and pharmacodynamic properties of eptifibatide in subjects with normal or impaired renal function Clin Ther 26 2004 390 398
42. K.B. Alton, T. Kosoglou, S. Baker, M.B. Affrime, M.N. Cayen, and J.E. Patrick Disposition of 14C-eptifibatide after intravenous administration to healthy men Clin Ther 20 1998 307 323
43. E.M. Ohman, N.S. Kleiman, G. Gacioch, S.J. Worley, F.I. Navetta, and J.D. Talley Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators Circulation 95 1997 846 854
44. J.P. Collet, G. Montalescot, C. Lesty, and J.W. Weisel A structural and dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots Circ Res 90 2002 428 434
45. S. Atar, H. Luo, Y. Birnbaum, T. Nagai, and R.J. Siegel Augmentation of in-vitro clot dissolution by low frequency high-intensity ultrasound combined with antiplatelet and antithrombotic drugs J Thromb Thrombolysis 11 2001 223 228
46. L.A. Robbie, B. Bennett, A.M. Croll, P.A. Brown, and N.A. Booth Proteins of the fibrinolytic system in human thrombi Thromb Haemost 75 1996 127 133
47. V. Menon, R.A. Harrington, J.S. Hochman, C.P. Cannon, S.D. Goodman, and R.G. Wilcox Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 549S 575S